Nordson Agrees To Acquire Atrion For About $800 Mln

(RTTNews) - Nordson Corporation (NDSN) Tuesday said it has agreed to acquire Atrion Corporation (ATRI), a supplier of medical devices and components in a transaction valued about $800 million, to be paid in cash.

Atrion is a manufacturer of proprietary medical products, with annual revenue of nearly $169 million in 2023.

The purchase price of $460.00 per share reflects a valuation of 15 times Atrion's 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership.

"We have long admired Atrion's technology portfolio, and today's announcement represents a step forward in expanding our medical offerings for our customers. Leveraging our NBS Next growth framework and medical business expertise, we see significant operational synergies, while supporting the long-term growth of the business," said Sundaram Nagarajan, president and chief executive officer of Nordson.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.